Testing effectiveness (Phase 2)Study completedNCT00827918
What this trial is testing
Test the Safety and Efficacy of MK-8998 in Acutely Psychotic Participants With Schizophrenia (MK-8998-004)
Who this might be right for
Schizophrenia
Merck Sharp & Dohme LLC 216